Advanced
  Home Compare Reports

Comparison with Similar Reports

Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hosp...

Publisher:        MarketsandMarkets

# of Pages:        260

Rating: 

1 User License $4,950

Publication Date:  February, 2022

Price:       $4,950 / User License




1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 VENTILATORS MARKET SEGMENTATION 34
FIGURE 2 VENTILATORS MARKET, BY REGION 34
1.4 YEARS CONSIDERED 35
1.5 CURRENCY 35
TABLE 1 STANDARD CURRENCY CONVERSION RATES 35
1.6 LIMITATIONS 36
1.7 STAKEHOLDERS 36
1.8 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 3 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 4 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS:
SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (VENTILATORS MARKET) 42
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. 45
FIGURE 10 SUPPLY-SIDE MARKET SIZE ESTIMATION: VENTILATORS MARKET (2020) 46
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR THE VENTILATORS MARKET (2021–2026) 47
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 13 TOP-DOWN APPROACH 48
 
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 50
FIGURE 14 DATA TRIANGULATION METHODOLOGY 50
2.4 MARKET SHARE ESTIMATION 51
2.5 STUDY ASSUMPTIONS 51
2.6 LIMITATIONS 51
2.6.1 METHODOLOGY-RELATED LIMITATIONS 52
2.7 RISK ASSESSMENT 52
TABLE 2 RISK ASSESSMENT: VENTILATORS MARKET 52
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE VENTILATORS MARKET 52
3 EXECUTIVE SUMMARY 54
FIGURE 15 VENTILATORS MARKET, BY MOBILITY, 2021 VS. 2026 (USD MILLION) 54
FIGURE 16 VENTILATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 17 VENTILATORS MARKET, BY INTERFACE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 18 VENTILATORS MARKET, BY MODE, 2021 VS. 2026 (USD MILLION) 56
FIGURE 19 VENTILATORS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 56
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF THE VENTILATORS MARKET 57
4 PREMIUM INSIGHTS 58
4.1 VENTILATORS MARKET OVERVIEW 58
FIGURE 21 COVID-19 PANDEMIC AND GROWTH IN THE PREVALENCE OF CHRONIC RESPIRATORY DISEASES ARE DRIVING THE GROWTH OF THE VENTILATORS MARKET 58
4.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY & COUNTRY (2020) 59
FIGURE 22 INTENSIVE CARE VENTILATORS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC VENTILATORS MARKET IN 2020 59
4.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
FIGURE 23 CHINA TO REGISTER THE HIGHEST GROWTH IN THE VENTILATORS MARKET DURING THE FORECAST PERIOD 60
4.4 VENTILATORS MARKET: REGIONAL MIX 60
FIGURE 24 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET IN 2026 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 25 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 High prevalence of respiratory diseases 62
5.2.1.1.1 High prevalence of COPD and asthma 62
5.2.1.1.2 High prevalence of tobacco smoking 62
TABLE 3 PREVALENCE AND DEATHS CAUSED DUE TO SMOKING 63
5.2.1.2 Rapid growth in the global geriatric population 63
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION 63
5.2.1.3 Government initiatives toward increasing the availability of ventilators amidst the COVID-19 pandemic 63
5.2.1.4 Increasing number of patients transferred to intensive care units 64
5.2.1.5 Outbreak of the COVID-19 pandemic 64
5.2.1.6 Growing preference for home-based oxygen therapy 64
5.2.2 RESTRAINTS 64
5.2.2.1 Dearth of skilled medical workers 64
5.2.2.2 Over purchase of ventilators in hospitals 65
5.2.2.3 Reimbursement concerns 65
5.2.3 OPPORTUNITIES 65
5.2.3.1 Development of non-invasive and microprocessor-controlled portable ventilators 65
5.2.3.2 Growth in healthcare spending 66
TABLE 4 TOTAL HEALTH EXPENDITURE PER CAPITA IN PURCHASING
POWER PARITY (USD) 66
5.2.3.3 Cost advantages of home care services 66
5.2.3.4 Growth opportunities in emerging countries 66
5.2.4 CHALLENGES 67
5.2.4.1 Low awareness and a large population of undiagnosed & undertreated patients 67
5.2.4.2 Harmful effects of certain devices on neonates 67
6 INDUSTRY INSIGHTS 68
6.1 TECHNOLOGY ANALYSIS 68
6.1.1 ARTIFICIAL INTELLIGENCE IN THE VENTILATORS MARKET 68
6.1.1.1 Introduction 68
6.1.1.2 The future of healthcare—Big Data and artificial intelligence 68
6.1.1.3 Knowledge-based systems for ventilation management 69
FIGURE 27 AI INTEGRATION INTO VENTILATORS 69
6.1.1.4 COVID-19 to drive the demand for artificial intelligence in ventilators 69
6.1.2 SENSOR TECHNOLOGIES IN VENTILATORS 70
6.1.2.1 Introduction 70
6.1.2.2 Flow sensors 70
6.1.2.3 Oxygen sensors 71
6.1.2.4 Pressure sensors 71
6.1.3 TECHNOLOGIES WITH HIGH-GROWTH POTENTIAL 72
6.1.3.1 E-Nose technology 72
6.1.3.2 MEMS technology 72
6.1.3.3 Electrochemical technology 72
6.1.3.4 Paramagnetic technology 73
6.1.3.5 Wireless gas sensor technology 73
 
6.2 INDUSTRY TRENDS 73
TABLE 5 MARKET CONSOLIDATION AND THE RISING DEMAND FOR PORTABLE VENTILATORS ARE THE MAJOR TRENDS IN THE MARKET 73
6.2.1 RISING DEMAND FOR ENHANCED PORTABLE AND COMPACT VENTILATORS 74
6.2.2 CONSOLIDATION OF THE MARKET 74
FIGURE 28 RECENT ACQUISITIONS IN THE MARKET 74
6.2.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS 75
6.2.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATION 75
6.2.5 NON-MEDICAL COMPANIES ENTERING THE MARKET TO CATER TO THE INCREASING DEMAND FOR VENTILATORS 75
6.3 FACTOR ANALYSIS 76
6.3.1 POPULATION SCENARIO 76
FIGURE 29 TOTAL POPULATION, BY COUNTRY/REGION 76
FIGURE 30 URBAN POPULATION, BY COUNTRY/REGION 76
FIGURE 31 GERIATRIC POPULATION (AGED ABOVE 65 YEARS) 77
6.3.2 HEALTHCARE EXPENDITURE 78
FIGURE 32 THE US ACCOUNTED FOR THE HIGHEST HEALTHCARE
EXPENDITURE (% OF GDP) 78
6.3.3 TARGET POPULATION 79
FIGURE 33 COVID-19 POPULATION: TOTAL POPULATION VS. RECOVERED POPULATION 79
6.4 PRICING ANALYSIS 79
TABLE 6 AVERAGE SELLING PRICE OF VENTILATORS OFFERED BY TOP PLAYERS 79
6.5 VALUE CHAIN ANALYSIS 80
FIGURE 34 VALUE CHAIN: VENTILATORS MARKET 81
6.6 ECOSYSTEM MAPPING 81
FIGURE 35 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 82
6.7 SUPPLY CHAIN ANALYSIS 82
6.8 PORTER’S FIVE FORCES ANALYSIS 84
TABLE 7 PORTER’S FIVE FORCES ANALYSIS 84
6.8.1 THREAT OF NEW ENTRANTS 84
6.8.2 THREAT OF SUBSTITUTES 85
6.8.3 BARGAINING POWER OF SUPPLIERS 85
6.8.4 BARGAINING POWER OF BUYERS 85
6.8.5 INTENSITY OF COMPETITIVE RIVALRY 85
6.9 REGULATORY ANALYSIS 86
6.9.1 NORTH AMERICA 86
6.9.1.1 US 86
6.9.1.2 Canada 86
6.9.2 EUROPE 86
6.9.3 ASIA PACIFIC 86
6.9.3.1 Japan 86
6.9.3.2 China 87
6.9.3.3 India 87
6.10 PATENT ANALYSIS 87
6.10.1 PATENT PUBLICATION TRENDS FOR VENTILATORS 87
FIGURE 37 GLOBAL PATENT PUBLICATION TRENDS IN THE VENTILATORS MARKET, 2015–2020 88
6.10.2 TOP APPLICANTS (COMPANIES) OF VENTILATOR PATENTS 88
FIGURE 38 TOP COMPANIES THAT APPLIED FOR VENTILATOR PATENTS, 2015–2020 88
6.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE VENTILATORS MARKET 89
FIGURE 39 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR VENTILATOR PATENTS, 2015–2020 89
6.11 TRADE ANALYSIS 89
TABLE 8 VENTILATOR EXPORT AND IMPORT DATA, BY COUNTRY 89
6.12 CASE STUDY ANALYSIS 90
TABLE 9 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES 90
TABLE 10 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS 91
6.13 IMPACT OF COVID-19 ON THE VENTILATORS MARKET 91
7 VENTILATORS MARKET, BY MOBILITY 92
7.1 INTRODUCTION 93
TABLE 11 VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 93
7.2 INTENSIVE CARE VENTILATORS 93
TABLE 12 MAJOR PRODUCTS: ICU VENTILATORS 94
TABLE 13 INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 95
TABLE 14 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
TABLE 15 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 96
7.2.1 HIGH-END ICU VENTILATORS 96
7.2.1.1 Improving healthcare infrastructure and rising healthcare expenditure in developing countries to drive market growth 96
TABLE 16 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 17 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 98
7.2.2 MID-END ICU VENTILATORS 98
7.2.2.1 Mid-end ICU ventilators are in high demand owing to the
COVID-19 pandemic 98
TABLE 18 MID-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 19 MID-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (UNITS) 100
7.2.3 BASIC ICU VENTILATORS 100
7.2.3.1 Basic ICU ventilators are equipped with minimal features as compared to high-end and mid-end ICU ventilators 100
TABLE 20 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 21 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 102
7.3 PORTABLE/TRANSPORTABLE VENTILATORS 102
7.3.1 LOW WEIGHT AND ROBUST NATURE HAVE INCREASED THE DEMAND FOR PORTABLE/TRANSPORTABLE VENTILATORS 102
TABLE 22 MAJOR PRODUCTS: PORTABLE/TRANSPORTABLE VENTILATORS 103
TABLE 23 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
TABLE 24 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (UNITS) 105
8 VENTILATORS MARKET, BY TYPE 106
8.1 INTRODUCTION 107
TABLE 25 VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
8.2 ADULT/PEDIATRIC VENTILATORS 107
8.2.1 INCREASING NUMBER OF COVID-19 CASES AMONG ADULTS DRIVING THE DEMAND FOR ADULT VENTILATORS 107
TABLE 26 ADULT/PEDIATRIC VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
8.3 NEONATAL/INFANT VENTILATORS 108
8.3.1 NEW TECHNOLOGIES AND INNOVATIONS IN THE FIELD OF NEONATAL VENTILATORS TO DRIVE MARKET GROWTH 108
TABLE 27 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
9 VENTILATORS MARKET, BY INTERFACE 110
9.1 INTRODUCTION 111
TABLE 28 VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 111
9.2 INVASIVE VENTILATION 111
9.2.1 INCREASING CASES OF COVID-19 AND RISING PREVALENCE OF RESPIRATORY DISEASES TO SUPPORT MARKET GROWTH 111
TABLE 29 INVASIVE VENTILATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
9.3 NON-INVASIVE VENTILATION 112
9.3.1 INCREASING ADOPTION OF NON-INVASIVE VENTILATION AMONG END USERS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 112
TABLE 30 NON-INVASIVE VENTILATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 113
10 VENTILATORS MARKET, BY END USER 114
10.1 INTRODUCTION 115
TABLE 31 VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 115
10.2 HOSPITALS & CLINICS 115
10.2.1 GROWING PATIENT VOLUMES DUE TO COVID-19 TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 115
TABLE 32 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2019–2026 (USD MILLION) 116
 
10.3 AMBULATORY CARE CENTERS 116
10.3.1 GROWING NUMBER OF OUTPATIENT VISITS TO DRIVE GROWTH IN THIS
END-USER SEGMENT 116
TABLE 33 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 117
10.4 EMERGENCY MEDICAL SERVICES 118
10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET GROWTH IN THE COMING YEARS 118
TABLE 34 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 118
10.5 HOME CARE SETTINGS 119
10.5.1 HOME CARE VENTILATORS ARE CONVENIENT AND CAN BE USED IN THE COMFORT OF THE PATIENT’S HOME—KEY FACTORS DRIVING MARKET GROWTH 119
TABLE 35 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2019–2026 (USD MILLION) 120
11 VENTILATORS MARKET, BY REGION 121
11.1 INTRODUCTION 122
FIGURE 40 CHINA TO REGISTER THE HIGHEST GROWTH RATE IN THE VENTILATORS MARKET DURING THE FORECAST PERIOD 122
TABLE 36 VENTILATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 123
11.2 NORTH AMERICA 123
FIGURE 41 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT 124
TABLE 37 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 38 NORTH AMERICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 125
TABLE 39 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 40 NORTH AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 41 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 126
TABLE 42 NORTH AMERICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 126
TABLE 43 NORTH AMERICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 126
11.2.1 US 127
11.2.1.1 The US dominated the North American ventilators market in 2020 127
TABLE 44 US: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 127
TABLE 45 US: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 128
TABLE 46 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 47 US: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 48 US: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 128
TABLE 49 US: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 129
TABLE 50 US: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 129
11.2.2 CANADA 129
11.2.2.1 Increasing incidence of COPD is driving the adoption of ventilators in Canada 129
TABLE 51 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 130
TABLE 52 CANADA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 130
TABLE 53 CANADA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 131
TABLE 54 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 55 CANADA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 56 CANADA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 132
TABLE 57 CANADA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 132
TABLE 58 CANADA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 132
11.3 EUROPE 133
FIGURE 42 EUROPE: VENTILATORS MARKET SNAPSHOT 134
TABLE 59 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 60 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 135
TABLE 61 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 62 EUROPE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 63 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 136
TABLE 64 EUROPE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 136
TABLE 65 EUROPE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 137
11.3.1 GERMANY 137
11.3.1.1 Germany dominated the ventilators market in Europe in 2019 137
TABLE 66 GERMANY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 137
TABLE 67 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 138
TABLE 68 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 69 GERMANY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 70 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 138
TABLE 71 GERMANY: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 139
TABLE 72 GERMANY: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 139
11.3.2 FRANCE 139
11.3.2.1 The highly advanced and well-established healthcare system in France driving market growth 139
TABLE 73 FRANCE: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 140
TABLE 74 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 140
TABLE 75 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 76 FRANCE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 77 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 141
TABLE 78 FRANCE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 141
TABLE 79 FRANCE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 142
11.3.3 UK 142
11.3.3.1 Increasing healthcare expenditure is driving the growth of the ventilators market in the country 142
TABLE 80 UK: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 143
TABLE 81 UK: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 143
TABLE 82 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 83 UK: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 84 UK: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 144
TABLE 85 UK: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 144
TABLE 86 UK: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 145
11.3.4 ITALY 145
11.3.4.1 Presence of a well-developed healthcare system in the country and rapid growth in the aging population to drive market growth 145
TABLE 87 ITALY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 146
TABLE 88 ITALY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 146
TABLE 89 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 90 ITALY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 91 ITALY: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 147
TABLE 92 ITALY: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 147
TABLE 93 ITALY: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 148
11.3.5 SPAIN 148
11.3.5.1 Increasing geriatric population to drive market growth in Spain 148
TABLE 94 SPAIN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 148
TABLE 95 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 149
TABLE 96 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 97 SPAIN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 98 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 150
TABLE 99 SPAIN: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 150
TABLE 100 SPAIN: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 150
11.3.6 NETHERLANDS 151
11.3.6.1 Increasing patient population to support market growth in the Netherlands 151
TABLE 101 NETHERLANDS: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 151
TABLE 102 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 151
TABLE 103 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 104 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 105 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 152
TABLE 106 NETHERLANDS: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 153
TABLE 107 NETHERLANDS: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 153
11.3.7 REST OF EUROPE 153
TABLE 108 ROE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 154
TABLE 109 ROE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 110 ROE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 111 ROE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 155
TABLE 112 ROE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 155
TABLE 113 ROE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 155
11.4 ASIA PACIFIC 156
FIGURE 43 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT 157
TABLE 114 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
TABLE 115 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 158
TABLE 116 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 117 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 118 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 159
TABLE 119 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 159
TABLE 120 ASIA PACIFIC: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 160
11.4.1 JAPAN 160
11.4.1.1 Japan’s established healthcare system to support market growth during the forecast period 160
TABLE 121 JAPAN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 161
TABLE 122 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 161
TABLE 123 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 124 JAPAN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 125 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 162
TABLE 126 JAPAN: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 162
TABLE 127 JAPAN: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 163
11.4.2 CHINA 163
11.4.2.1 Healthcare development and initiatives to curb COVID-19 to stimulate the market growth for ventilators in China 163
TABLE 128 CHINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 164
TABLE 129 CHINA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 164
TABLE 130 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 131 CHINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 132 CHINA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 165
TABLE 133 CHINA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 165
TABLE 134 CHINA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 166
11.4.3 INDIA 166
11.4.3.1 Increasing COVID-19 patient volume to drive the ventilators market in India 166
TABLE 135 INDIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 167
TABLE 136 INDIA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 167
TABLE 137 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 138 INDIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 139 INDIA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 168
TABLE 140 INDIA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 168
TABLE 141 INDIA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 169
11.4.4 AUSTRALIA 169
11.4.4.1 High prevalence of chronic diseases to drive the demand for ventilators in Australia during the forecast period 169
TABLE 142 AUSTRALIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 170
TABLE 143 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 170
TABLE 144 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 145 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 146 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 171
TABLE 147 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 171
TABLE 148 AUSTRALIA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 172
11.4.5 REST OF ASIA PACIFIC 172
TABLE 149 ROAPAC: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 172
TABLE 150 ROAPAC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 151 ROAPAC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 152 ROAPAC: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 173
TABLE 153 ROAPAC: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 174
TABLE 154 ROAPAC: VENTILATORS MARKET, BY END USER,2019–2026 (USD MILLION) 174
11.5 LATIN AMERICA 174
TABLE 155 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 175
TABLE 156 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 175
TABLE 157 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 158 LATIN AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 159 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 176
TABLE 160 LATIN AMERICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 176
TABLE 161 LATIN AMERICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 177
11.5.1 BRAZIL 177
11.5.1.1 Healthcare infrastructure improvement to support market growth in Brazil 177
TABLE 162 BRAZIL: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 178
TABLE 163 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 178
TABLE 164 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 165 BRAZIL: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 166 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 82019–2026 (USD MILLION) 179
TABLE 167 BRAZIL: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 179
TABLE 168 BRAZIL: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 180
11.5.2 MEXICO 180
11.5.2.1 Rising obesity rate to increase the incidence rate of respiratory diseases in Mexico 180
TABLE 169 MEXICO: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 181
TABLE 170 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 181
TABLE 171 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 172 MEXICO: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 173 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 182
TABLE 174 MEXICO: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 182
TABLE 175 MEXICO: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 183
11.5.3 ARGENTINA 183
11.5.3.1 Rising prevalence of respiratory diseases in Argentina to drive market growth 183
TABLE 176 ARGENTINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 183
TABLE 177 ARGENTINA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 184
TABLE 178 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 179 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 180 ARGENTINA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 185
TABLE 181 ARGENTINA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 185
TABLE 182 ARGENTINA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 185
11.5.4 REST OF LATIN AMERICA 186
TABLE 183 ROLATAM: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 186
TABLE 184 ROLATAM: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 185 ROLATAM: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 186 ROLATAM: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 187
TABLE 187 ROLATAM: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 187
TABLE 188 ROLATAM: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 187
11.6 MIDDLE EAST & AFRICA 188
11.6.1 GROWING GERIATRIC POPULATION TO DRIVE GROWTH IN THE MIDDLE EAST & AFRICA 188
TABLE 189 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 188
TABLE 190 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 191 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 192 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 189
TABLE 193 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 190
TABLE 194 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 190
12 COMPETITIVE LANDSCAPE 191
12.1 INTRODUCTION 191
TABLE 195 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO JANUARY 2022) 191
12.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS 192
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATORS MARKET 192
12.3 MARKET SHARE ANALYSIS 192
FIGURE 45 VENTILATORS MARKET SHARE, BY KEY PLAYER, 2020 193
12.4 COMPETITIVE SCENARIO 194
12.4.1 PRODUCT LAUNCHES 194
TABLE 196 VENTILATORS MARKET: SERVICE LAUNCHES
(JANUARY 2018 TO JANUARY 2022) 194
12.4.2 DEALS 195
TABLE 197 VENTILATORS MARKET: DEALS (JANUARY 2018 TO JANUARY 2022) 195
12.4.3 OTHER DEVELOPMENTS 196
TABLE 198 VENTILATORS MARKET: OTHER DEVELOPMENTS
(JANUARY 2018 TO JANUARY 2022) 196
12.5 COMPETITIVE BENCHMARKING 197
12.5.1 FOOTPRINT OF KEY PLAYERS IN THE VENTILATORS MARKET 197
12.5.2 MOBILITY FOOTPRINT OF COMPANIES 198
12.5.3 TYPE FOOTPRINT OF COMPANIES 199
12.5.4 INTERFACE FOOTPRINT OF COMPANIES 200
12.5.5 MODE FOOTPRINT OF COMPANIES 201
12.5.6 END-USER FOOTPRINT OF COMPANIES 202
12.5.7 REGIONAL FOOTPRINT OF COMPANIES 203
FIGURE 46 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN VENTILATORS MARKET 204
12.6 VENTILATORS MARKET: R&D EXPENDITURE 205
FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN THE VENTILATORS MARKET (2019 VS. 2020) 205
12.7 COMPANY EVALUATION MATRIX 205
12.7.1 STARS 206
12.7.2 EMERGING LEADERS 206
12.7.3 PERVASIVE PLAYERS 206
12.7.4 EMERGING COMPANIES 206
FIGURE 48 VENTILATORS MARKET: GLOBAL COMPANY EVALUATION MATRIX 207
12.8 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 207
12.8.1 PROGRESSIVE COMPANIES 207
12.8.2 STARTING BLOCKS 208
12.8.3 RESPONSIVE COMPANIES 208
12.8.4 DYNAMIC COMPANIES 208
FIGURE 49 VENTILATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS 208
13 COMPANY PROFILES 209
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 KEY PLAYERS 209
13.1.1 KONINKLIJKE PHILIPS N.V. 209
TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 209
FIGURE 50 COMPANY SNAPSHOT: KONINKLIJKE PHILIPS N.V. (2020) 210
13.1.2 RESMED 213
TABLE 200 RESMED INC.: BUSINESS OVERVIEW 213
FIGURE 51 COMPANY SNAPSHOT: RESMED (2020) 214
13.1.3 MEDTRONIC 217
TABLE 201 MEDTRONIC: BUSINESS OVERVIEW 217
FIGURE 52 COMPANY SNAPSHOT: MEDTRONIC (2020) 218
13.1.4 VYAIRE MEDICAL, INC. 221
TABLE 202 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW 221
13.1.5 GETINGE AB 224
TABLE 203 GETINGE AB: BUSINESS OVERVIEW 224
FIGURE 53 COMPANY SNAPSHOT: GETINGE AB (2020) 225
13.1.6 DRÄGERWERK AG & CO. KGAA 228
TABLE 204 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 228
FIGURE 54 COMPANY SNAPSHOT: DRÄGERWERK AG & CO. KGAA (2020) 228
13.1.7 SMITHS GROUP PLC 231
TABLE 205 SMITHS GROUP PLC: BUSINESS OVERVIEW 231
FIGURE 55 COMPANY SNAPSHOT: SMITHS GROUP PLC (2020) 232
13.1.8 HAMILTON MEDICAL 234
TABLE 206 HAMILTON MEDICAL: BUSINESS OVERVIEW 234
13.1.9 GE HEALTHCARE 236
TABLE 207 GE HEALTHCARE: BUSINESS OVERVIEW 236
FIGURE 56 COMPANY SNAPSHOT: GE HEALTHCARE (2020) 237
13.1.10 FISHER & PAYKEL HEALTHCARE LIMITED 239
TABLE 208 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW 239
FIGURE 57 COMPANY SNAPSHOT: FISHER & PAYKEL HEALTHCARE LIMITED (2020) 240
13.2 OTHER PLAYERS 242
13.2.1 AIR LIQUIDE 242
TABLE 209 AIR LIQUIDE: BUSINESS OVERVIEW 242
FIGURE 58 COMPANY SNAPSHOT: AIR LIQUIDE (2020) 243
13.2.2 ASAHI KASEI CORPORATION 245
TABLE 210 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 245
FIGURE 59 COMPANY SNAPSHOT: ASAHI KASEI CORPORATION (2020) 246
13.2.3 ALLIED HEALTHCARE PRODUCTS, INC. 248
TABLE 211 ALLIED HEALTH PRODUCTS, INC.: BUSINESS OVERVIEW 248
FIGURE 60 COMPANY SNAPSHOT: ALLIED HEALTH PRODUCTS, INC. (2020) 248
13.2.4 NIHON KOHDEN CORPORATION 250
TABLE 212 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 250
FIGURE 61 COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION (2020) 251
13.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 253
13.2.6 AXCENT MEDICAL GMBH 253
13.2.7 METRAN CO., LTD. 254
13.2.8 MAGNAMED 254
13.2.9 LEISTUNG ENGINEERING PVT. LTD. 255
13.2.10 AVASARALA TECHNOLOGIES LIMITED 255
13.2.11 AIRON CORPORATION 256
13.2.12 TRITON ELECTRONIC SYSTEMS LTD. 256
13.2.13 HILL-ROM HOLDINGS, INC. 257
13.2.14 BIO-MED DEVICES, INC. 257
13.2.15 HEYER MEDICAL AG 258
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 259
14.1 DISCUSSION GUIDE 259
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 264
14.3 AVAILABLE CUSTOMIZATIONS 266
14.4 RELATED REPORTS 266
14.5 AUTHOR DETAILS 267

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127